Share this article
Share this article
International Expert Opinion and Implementation Guidance outlines Ketamine and Esketamine treatment parameters setting the standard for the clinical implementation of these rapid-acting treatments in treatment resistant depression
Guidance published in the official Journal of the American Psychiatric Association establishes Braxia Scientific as an international leader in the rapidly evolving industry of Ketamine, Esketamine and rapid acting antidepressants
TORONTO, June 9, 2021 /PRNewswire/ - Braxia Scientific Corp. ( Braxia , or the Company ), (CSE: BRAX) (OTC: BRAXF) (FWB: 496), a medical research company with clinics providing novel ketamine treatments for persons with depression and related disorders, is pleased to announce the American Journal of Psychiatry, the most widely read psychiatric journal in the world, has published the International Expert Opinion and Implementation Guidance (the Guidelines ) for the clinical use of rapi
/PRNewswire/ Dynacure, a clinical-stage company focused on developing and commercializing novel therapies to transform the lives of patients with rare.
/PRNewswire/ AntlerA has applied its next generation programmable ANT platform to develop therapeutics for treating retinopathies. Blood vessels that supply.
/PRNewswire/ MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, and Kyowa Kirin Co., Ltd..
NASA/Methuselah Challenge Winners Make History by Engineering, Sustaining Live Human Tissue in a Laboratory
Achievement Breaks Scientific Logjam to Help Solve the Organ Shortage
News provided by
Share this article
Share this article
WASHINGTON, June 9, 2021 /PRNewswire/ Methuselah Foundation, which co-sponsored the Vascular Tissue Challenge with NASA, today announced the award-winning researchers achieved scientific breakthroughs that promise to dramatically change the future of human health.
The first- and second-place Challenge winners announced by NASA today are the first scientific teams to engineer and sustain thick functioning human tissue in a lab. The Challenge, first conceived by Methuselah Foundation in 2013, was conducted to increase the pace of bioengineering innovations to benefit humans on Earth and future space explorers.